The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute.
Tolaney SM, Lydon CA, Li T, Dai J, Standring A, Legor KA, Caparrotta CM, Schenker MP, Glazer DI, Tayob N, DuBois SG, Meyerhardt JA, Taplin ME, Johnson BE.
Tolaney SM, et al. Among authors: glazer di.
J Natl Cancer Inst. 2021 Nov 2;113(11):1453-1459. doi: 10.1093/jnci/djaa144.
J Natl Cancer Inst. 2021.
PMID: 32959883
Free PMC article.